|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.9 EUR | -1.64% |
|
+0.91% | -22.00% |
| Apr. 26 | Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 03 | Valbiotis: launch of Valbiotis PRO Cholesterol in May | CF |
Valbiotis SA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 0.785 million compared to EUR 0.298 million a year ago. Revenue was EUR 2.81 million compared to EUR 2.69 million a year ago.
Net loss was EUR 12.31 million compared to EUR 8.68 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -22.00% | 65.67M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
VALBIOTIS 
